Kishimoto Takashi Kei 4
4 · SELECTA BIOSCIENCES INC · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Kishimoto Takashi Kei
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-01-03+72,000→ 271,769 total - Award
Employee Stock Option (right to buy)
2022-01-03+340,000→ 340,000 totalExercise: $3.31Exp: 2032-01-02→ Common Stock (340,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 3, 2023. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 3, 2026.
- [F2]This option vests as to 25% on January 3, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.